Wits partners with Biovac to develop skills that will help in producing vaccines By Chulumanco Mahamba Share Johannesburg - Wits University has partnered with Cape Town-based bio-pharmaceutical company Biovac to develop skills to produce viral vectored vaccines in South Africa. Wits University’s Antiviral Gene Therapy Research Unit (AGTRU), via Wits Enterprise, has joined with Cape Town-based bio-pharmaceutical company Biovac in partnership to develop the skills capacity to produce viral vectored vaccines. AGTRU has specialised expertise in advancing gene therapy for viral infections. Viruses can be genetically engineered for gene therapy to treat genetic diseases, viral infections, develop vaccines and boost immunity.